For years, I’ve been slightly afraid to speak up against my cardiology colleagues. But now, I am no longer afraid.
After seven years of medical school and residency, and another seven as an attending physician, I’ve reached a place of lightness — a place where intuition, clinical experience, and my moral compass as both a physician and yoga teacher finally align.
For too long, I stayed quiet. Behind closed doors, I would gently tell my patients that not everything we call “standard of care” deserves our blind faith. That medicine, like all human institutions, is vulnerable to money, ego, and fear.
And now, evidence has emerged that validates what my gut has whispered all along.
The Cracks in the Cholesterol Dogma
Dr. Larry Kaskel, an internist and lipidologist, recently wrote a courageous article on Doximity — one that should shake the medical world if we’re truly committed to science.
For decades, physicians have been trained to treat the cholesterol hypothesis as gospel: lower LDL, save lives. Statins were portrayed not as optional tools, but as moral imperatives. To question them was to risk being labeled reckless or “anti-science.”
But Kaskel revisited several randomized controlled trials conveniently left out of major meta-analyses — including the influential Silverman et al. study that helped solidify the statin narrative. These excluded trials tell a far less flattering story.
-
In the EXCEL trial, all three pravastatin dose groups showed more coronary heart disease deaths than placebo.
-
In DEBATE, mortality was higher in the statin group — both total deaths and deaths from heart disease.
-
In GISSI-HF, patients on rosuvastatin fared no better than placebo — if anything, slightly worse.
-
SEAS and CORONA told similar tales: no survival benefit, and in some cases, a hint of harm.
-
And the largest of all, IMPROVE-IT, involving nearly 18,000 post-ACS patients, found that adding ezetimibe to a statin lowered LDL cholesterol — but did not lower mortality one bit.
Put simply: placebo did as well, or better, than statins in preventing death.
These aren’t fringe studies. They are large, carefully conducted trials — but they were ignored. Omitted. Erased from the narrative. Because they didn’t fit the story that billions of dollars depend on.
When you see that, you can’t unsee it.
The Real Disease: Fear and Financial Control
Let’s be honest. Medicine is not immune to indoctrination. Many of us were raised in a system where “evidence-based” really meant “industry-approved.”
Pharma representatives brought us lunch, sponsored our conferences, and paid for “educational” dinners. We were told we were practicing science — but much of what we absorbed was marketing.
When a doctor questions these norms, the reaction isn’t curiosity — it’s defensiveness. “You’re going against the guidelines.” “You’ll get sued if something happens.”
And that’s where the second, quieter industry comes in — the malpractice machine.
The Malpractice Industry: Fear as a Business Model
The American malpractice system, once intended to protect patients, has evolved into a multibillion-dollar fear industry.
Take Morgan & Morgan, for example — one of the largest personal injury firms in the nation. In 2024 alone, they spent $1.4 million on campaign contributions and an estimated $350 million per year on advertising. Their billboards, commercials, and social media ads have become unavoidable — conditioning the public to equate any poor outcome with wrongdoing.
Their influence extends beyond public opinion. They lobby lawmakers and strategically shape jurisdictional rules. For example, as of January 1, 2023, the Pennsylvania Supreme Court repealed a long-standing rule that had limited medical malpractice cases to the county where the alleged negligence occurred. This change overturned more than twenty years of precedent and now allows cases to be filed in any county where a defendant regularly conducts business.
In practical terms, that means a malpractice claim that originates in Montgomery County can now be moved to Philadelphia County — a venue statistically associated with higher verdicts and less medically informed juries. It’s a change celebrated by trial attorneys but deeply concerning for physicians and hospitals already practicing under constant legal pressure.
This is not justice. It’s strategy — and it’s driven by greed.
The Two Sides of the Standard of Care
The concept of “standard of care” was, at its core, created with good intentions. It was meant to guide, not control — to help clinicians make consistent, evidence-based decisions that improve patient outcomes.
There are many examples where these guidelines genuinely help us reason through next steps. For instance, when lung nodules are found on imaging, established recommendations help us determine whether follow-up or further testing is needed — based on size, number, and risk factors. These steps are grounded in data on what leads to the best outcomes for patients.
The same goes for infection management. We have thoughtful standards for when antibiotics are appropriate, and when they aren’t — designed to reduce overuse and misuse. These frameworks support us in balancing benefit and harm, especially in everyday cases like sore throats or ear infections.
That’s the good side of standard of care — the side built on science, outcomes, and the desire to do what’s best for our patients.
But there’s another side — the shadow side of standard of care — and it’s the one driven by fear.
When fear of litigation begins to overshadow scientific reasoning, doctors start following protocols not because they believe in them, but because they’re afraid not to. Over time, what began as a safety net becomes a cage. We stop asking whether a guideline makes sense for the person sitting in front of us, and we start asking only, “Will this protect me in court?”
And that’s where medicine begins to fracture.
We’ve seen what happens when profit and fear infiltrate our guidelines — think of the opioid crisis, when high-dose narcotics were promoted for decades as the “standard of care,” pushed by pharmaceutical marketing and legitimized by complacent institutions. Were those standards truly about science? Or were they shaped by corporate greed and reinforced by physicians too afraid or too pressured to question them?
These are the questions we need to start asking again:
-
Is this guideline truly based on solid science and patient-centered outcomes?
-
Or has it become a product of fear, profit, or political influence?
In Pennsylvania, this tension is amplified by a desperate need for tort reform. We sit at one extreme of the spectrum — a culture where frivolous lawsuits are not only tolerated but incentivized. Billboards for large malpractice firms line the I-95 corridor, serving as a visual reminder of the climate of fear.
I’ve lived in Europe, where the pendulum swings the other way — where patients often have almost no recourse when harm occurs. That isn’t right either.
The U.S. system needs balance — one where legitimate harm is fairly addressed, but physicians aren’t forced to practice medicine from a place of self-protection rather than thoughtful care.
Because medicine practiced from fear is no longer medicine — it’s defense. And our patients deserve better than that.
A Call for Awareness and Balance
We became doctors to heal — not to follow scripts written by systems that have become more complex and less humane than any of us intended.
It’s hard to practice in a climate where billion-dollar malpractice firms spend millions lobbying Congress each year, creating a legal culture that pushes physicians toward defensive medicine. It’s equally hard in a system shaped by pharmaceutical and insurance giants, whose financial influence quietly steers so many of our “standards of care.”
None of this is easy to talk about — but that’s exactly why we must start talking about it. Acknowledgement is the first step toward change.
We don’t fix this by vilifying anyone. We fix it by recognizing the pressures that have shaped modern medicine and by being honest about their impact on patient care.
The truth is, many guidelines are helpful and grounded in good science — they give structure, consistency, and clarity in an uncertain world. But some are built on shaky ground, reinforced by money, fear, or inertia. The task before us is not to reject all standards, but to learn to discern: Which ones are truly serving patients, and which are protecting institutions?
The more openly we can have that conversation, the more room we create for integrity to return to the heart of medicine.
Because when we practice with awareness — not fear, not blind compliance — we practice with freedom, humility, and humanity. And that is what our patients, and our profession, deserve.
Dr. Dana Mincer
Family Physician | Founder & Chief Visionary Officer, Love Health DPC
Advocate for ethical, lifestyle-based, patient-centered medicine
